Plus Therapeutics Announces Webinar To Present ReSPECT™ Glioblastoma Clinical Trial Update

Press/Media: Press / Media

PeriodNov 13 2020

Media coverage

19

Media coverage

  • TitlePlus Therapeutics Announces Webinar To Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletTheStreet.com
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletMorningstar.com
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitleWebinar to Present ReSPECT(TM) Glioblastoma Clinical Trial Update
    Media name/outletMarket News Publishing
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletStocksNewsFeed.com
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletYahoo! Canada
    CountryCanada
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletYahoo! Finance
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletDailyMagazine.News
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletMarketScreener.com
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT(TM) Glioblastoma Clinical Trial Update
    Media name/outletTD Ameritrade
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT ™ Glioblastoma Clinical Trial Update
    Media name/outletStockwatch
    CountryCanada
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletMarkets Business Insider
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletJotup
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletBioSpace
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT„¢ Glioblastoma Clinical Trial Update
    Media name/outletPrimeNewswire (Top News)
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletGlobeNewswire
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletBizWire Express
    CountryIndia
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletOne News Page
    CountryUnited Kingdom
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletOneNewsPage.us
    CountryUnited States
    Date11/13/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
    Media name/outletNewsR.in
    CountryIndia
    Date11/13/20
    PersonsAndrew Brenner